MASALA study

 Here are 3 crisp, exam-ready points from the MASALA study:

1. Early and higher cardiometabolic risk in South Asians
South Asian adults show earlier onset and higher prevalence of type 2 diabetes, prediabetes, hypertension, and dyslipidemia—often despite lower BMI. This is driven by greater insulin resistance, lower β-cell function, and adverse fat distribution (↑ visceral & hepatic fat, ↓ lean mass).

2. Heterogeneity + severe diabetes phenotype
Risk is not uniform across subgroups (e.g., higher diabetes in Pakistani-origin individuals, more hypertension in North Indians, more dyslipidemia in South Indians). A notable pattern is the “severe hyperglycemia” subtype—leaner individuals with β-cell dysfunction and higher subclinical atherosclerosis risk.

3. Implications for screening and prevention
Findings support earlier and more aggressive screening (even from young adulthood), use of tools like coronary artery calcium (CAC) for risk stratification, and recognition of South Asian ancestry as a risk-enhancing factor in guidelines. Lifestyle factors (diet, activity) remain key modifiable targets.

If you want, I can condense this further into a one-line mnemonic or viva-style answer.